Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2012-01-30
Target enrollment:
Participant gender:
Summary
Patients will be switched from their current medication for painful diabetic peripheral
neuropathy to evaluate the safety and efficacy of pregabalin as compared to placebo. All
patients will receive pregabalin, and half of patients will receive placebo at some point
during the study.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.